Navigation Links
CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting
Date:11/25/2008

WOONSOCKET, R.I., Nov. 25 /PRNewswire/ -- CVS Caremark (NYSE: CVS) announced today the findings from a yearlong study, suggesting that influenza vaccinations can help reduce the risk of hospitalizations in patients with chronic conditions. These findings will be presented on Tuesday, November 25th at the annual meeting of DMAA: The Care Continuum Alliance, in Hollywood, Fla.

"This data furthers our understanding of the positive impact of influenza vaccinations," said Marsha Moore, MD, Senior Vice President, Medical Affairs, CVS Caremark. "The results are an example of how our Proactive Pharmacy Care approach can help patients dealing with chronic conditions benefit from the positive impact of an annual influenza vaccination and can be an important tool for communicating the need for flu vaccine in this patient population."

The CVS Caremark study monitored the impact of influenza vaccination on subsequent hospitalization rates for all participants. Results indicated that for chronic disease patients who received the influenza vaccine there was a 19% reduction in hospitalization for all causes and a 24% reduction in flu and pneumonia-related hospitalizations.

The study and analysis evaluated 19,908 participants enrolled in a comprehensive common chronic disease management program. The subjects were selected from a continuously enrolled population of all ages -- all of whom were predetermined to have one of a number of chronic conditions including asthma, diabetes, coronary artery disease, heart failure or chronic obstructive pulmonary disease (COPD). Investigators assessed hospital visits in 2006, and the vaccinated and non-vaccinated groups had equal distributions of gender, age and co morbidities. The presence of influenza vaccine was derived from self-reported patient data as well as medical claims.

Influenza vaccination is one of the universal recommendations by the Centers for Disease Control and Prevention (CDC) for a specific cohort of patients of all ages, including those with chronic disease, as well as elderly and pediatric patients.

"By reducing the number of hospitalizations and overall risks of complications the appropriate use of the influenza vaccination could result in a number of benefits for patients, and even lower the costs of care for those who receive the vaccination," said Dr. Moore.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 6,800 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at cvscaremark.com/investors, as well as through the press room section of the Company's Web site, at cvscaremark.com/newsroom.

    Media Contact:

    Christine Cramer             Jon Tashjian
    CVS Caremark                 Weber Shandwick
    (401) 770-3317               (617) 520-7118
    ckcramer@cvs.com             j.tashjian@webershandwick.com

'/>"/>
SOURCE CVS Caremark
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CVS Caremark Named Finalist in URAC Annual Best Practices in Health Care Consumer Empowerment and Protection Awards
2. CVS Caremark Applauds FTCs Leadership on Follow-on Biologics
3. CVS Caremark All Kids Can Announces the Opening of a Boundless Playground in Los Angeles to Serve Children of All Abilities
4. CVS Caremark Names Troyen Brennan, MD, EVP, Chief Medical Officer
5. SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009
6. CVS Caremark Partners with Google Health to Provide Consumers with Online Access to their Prescription History through Caremark.com
7. CVS Caremark Reports Record Second Quarter Revenues, Operating Profit, and Earnings
8. CVS Caremark Employees Raise $1 Million and Increase Awareness for Children with Disabilities through Easter Seals Walk With Me Events Nationwide
9. CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008
10. CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can(TM) Baseball Camps at Fenway Park
11. CVS Caremark Honors Heroes in Womens Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... A new study from ... and Medicare rates for a variety of medical services in Illinois as of ... the 2015 Fee Schedule Rates in Illinois, are professional medical services, hospital ...
(Date:2/9/2016)... (PRWEB) , ... February 09, ... ... print and e-book publishing software, in partnership with Snowfall4pod Digital, creators of ... a comprehensive book publishing, content management, global distribution and print-on-demand network. , ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Establishment Labs, ... of Dr. David Hung to the company´s Board of Directors. , “We ... class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of Establishment ...
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain Research has ... field .” , As corresponding author Dr John F. Peppin says “Terminology matters, yet ... our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are replete ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Dr. Rassouli, ... whitening packages. Teeth whitening is among the most popular cosmetic procedures in dentistry today, ... whitening needs. This can put them at risk of teeth whitening-related damage. For a ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... The global prefilled syringes market accounted for $3,905.1 million ... with a CAGR of 12.9% during 2015-2020. Among the ... global prefilled syringes market, with 90.1% share in 2014. ... global market of prefilled syringes is up surging with ... demand for vaccines, increasing prevalence of chronic and lifestyle ...
Breaking Medicine Technology: